SubHero Banner

3rd Quarter 2018

Key topics in this quarter’s edition include:

  • canakinumab: To reduce the risk of recurrent cardiovascular events in stable post-myocardial infarction patients with elevated inflammatory markers, such as high-sensitivity C-reactive protein (hsCRP).
  • brexanolone: Treatment of postpartum depression.
  • baloxavir marboxil: Treatment of acute, uncomplicated influenza in patients 12 years of age and older.

Download PDF